I’m proud to be leading a bipartisan effort alongside Congresswoman Fischbach to drive investments in biomanufacturing that will have wide-reaching benefits for farmers, rural economies, consumers, and the environment.
Drive investments in biomanufacturing to strengthen the domestic supply chain and create new markets for American farmers.
Occurrences
introduced the Grocery, Farm, and Food Worker Stabilization Grant Program Act, legislation that would create a new, permanent grant program to provide stabilization payments to farm, grocery, and meatpacking workers in the case of a major disaster
Evidence
legacy_unverified · Source version not recorded · locator unknown
EDA announced approximately $51 million for the iFAB Tech Hub to scale precision fermentation and biomanufacturing projects, including facilities, equipment/capital access, and workforce training. The release says iFAB uses corn and soy feedstocks to create high-value food ingredients, materials, chemicals, and other outputs, and includes Budzinski saying she pushed for the resources.
legacy_unverified · Source version not recorded · locator unknown
H.R. 8137 was introduced by Rep. Fischbach with Rep. Budzinski and referred to Ways and Means. The bill would create a renewable materials production credit and a 30 percent renewable materials investment credit for qualified U.S. facilities producing materials from biomass.
Assessments
Budzinski can receive candidate credit for helping push federal investment into biomanufacturing: during her House term, EDA awarded about $51 million to the iFAB Tech Hub in Illinois for precision fermentation and biomanufacturing using corn and soy feedstocks, directly matching the promise’s themes of domestic supply chains and new markets for farmers. She also co-sponsored 2026 legislation to create renewable materials production and investment tax credits, showing continued effort. However, the broader promised outcome was not fully delivered: the tax-credit bill was only introduced/referred, and the evidence shows a substantial project-level investment rather than completion of a comprehensive domestic biomanufacturing supply-chain agenda.